Latest News

Friday, February 15, 2019

Dermatology Drugs Market to Reach $34.5 Billion by 2023

The dermatology drugs market is expected to reach $34.5 billion by 2023, a new report suggests. Research and Markets says that, among topical corticosteroids, retinoids, biologics, calcineurin in…

Read the full story

Friday, February 15, 2019

FDA Proposes Policy for New Competitive Generic Therapies Pathway

The FDA has issued a new policy it says is intended to improve access and increase competition for drugs that lack generic competition.  The new pathway for Competitive Generic Therapies (CGTs…

Read the full story

Thursday, February 14, 2019

New Guidelines Offer SRT Treatment Recommendations for Skin Cancers, Keloids

Superficial Radiation Therapy (SRT) should be first-line therapy for appropriate non-melanoma skin cancers in appropriate patients, according to new consensus guidelines published in The Journal …

Read the full story

Thursday, February 14, 2019

Rodan & Fields Takes on Teen Acne with Spotless

Rodan & Fields is launching Spotless, a patent-pending teen and young adult acne solution. The company is also updating its Unblemish Regimen with new formulas that feature Benzoyl Peroxide a…

Read the full story

Wednesday, February 13, 2019

Sienna Biopharmaceuticals: Promising Topline Results for SNA-001 for Hair Removal

Topline results from the pivotal trial of Sienna Biopharmaceuticals’ SNA-001 show that the topical agent in conjunction with an 810nm diode laser was statistically superior compared to vehicle p…

Read the full story

Wednesday, February 13, 2019

Study Shows 97% Cure Rate for Superficial Radiation Therapy for BCC and SCC

A new retrospective study shows a high cure rate exceeding 97 percent among older patients (mean age: 82.5 years) being treated for basal cell carcinoma (BCC) and squamous cell carcinomas (SCC) on the…

Read the full story

Wednesday, February 13, 2019

Two New Psoriasis Guidelines Address Comorbidities, Biologic Treatment

The American Academy of Dermatology and the National Psoriasis Foundation have released two new guidelines outlining best practices for treating psoriasis with a focus on comorbidities and biologic tr…

Read the full story

Tuesday, February 12, 2019

Stelatopia Emollient Face Cream Now Available from Mustela

Mustela Stelatopia Emollient Face Cream is now available, specifically designed for extremely dry to eczema-prone skin and gentle enough to use on newborns.  Formulated with Avocado Perseose…

Read the full story

Tuesday, February 12, 2019

FDA Grants 510(k) Clearance to Laseroptek’s PicoLO

Laseroptek’s PicoLO picosecond Nd:YAG laser is now U.S. Food and Drug Administration-cleared for marketing in dermatology and general and plastic surgery. According to the company, PicoLO gen…

Read the full story

Tuesday, February 12, 2019

Applied Biology to Enter into a License Agreement with Hairmore for Novel Traction Alopecia Rx

Applied Biology, Inc. is bringing its novel TAAR receptor agonist for the treatment of traction or ponytail alopecia to the Chinese market through a licensing deal with the Hairmore Group. When app…

Read the full story

Tuesday, February 12, 2019

Lutronic Genius RF Microneedling Platform Cleared by FDA

Lutronic has received FDA clearance of the Lutronic Genius™ platform for radiofrequency microneedling. The company says the device transmits energy more precisely into the skin.   …

Read the full story

Monday, February 11, 2019

MedPharm Ltd. Expands Partnership with Palvella Therapeutics, Inc. for PC Treatment

MedPharm Ltd, is expanding its partnership with Palvella Therapeutics, Inc. MedPharm has employed its formulation expertise to support Palvella’s development of a novel, high-strength …

Read the full story

Monday, February 11, 2019

International Awards for Social Responsibility in Dermatology Calls for Submissions

Applications are being accepted online for the 2019 International Awards for Social Responsibility in Dermatology.  This third edition of the Awards will recognize social initia…

Read the full story

Monday, February 11, 2019

Combination Surgical Excision/Laser Treatment Improves Outcomes, Patient Satisfaction for CMN

Combining lasers with surgical excision produces cosmetically superior results compared to laser-only treatments for small to medium congenital melanocytic nevi (CMN), according to a new review. Th…

Read the full story

Friday, February 08, 2019

Immunotherapy Appears Better Than Chemotherapy for Aggressive Merkle Cell Carcinoma

First-line therapy with Pembrolizumab may produce better responses and result in longer survival in Merkel cell carcinoma than conventional chemotherapy. The study, co-led by Suzanne Topalian, M.D.…

Read the full story
Load More